Cite
APA Citation
Usul Afsar, Ç., Karabulut, M., Karabulut, S., Alis, H., Gonenc, M., Dagoglu, N., Serilmez, M., & Tas, F. (n.d.). circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Journal of infection and chemotherapy, 23(4), 196–200. http://access.bl.uk/ark:/81055/vdc_100045083956.0x000024